Optimized virologic response in hepatitis C virus genotype 4 with peginterferon-α2a and ribavirin

被引:37
作者
Diago, M [1 ]
Hassanein, T
Rodés, J
Ackrill, AM
Sedarati, F
机构
[1] Univ Valencia, Gen Hosp, E-46003 Valencia, Spain
[2] Univ Calif San Diego, San Diego, CA 92103 USA
[3] Univ Barcelona, E-08007 Barcelona, Spain
[4] Hoffmann La Roche, Nutley, NJ USA
关键词
D O I
10.7326/0003-4819-140-1-200401060-00035
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:72 / 73
页数:2
相关论文
共 5 条
[1]   Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. [J].
Fried, MW ;
Shiffman, ML ;
Reddy, KR ;
Smith, C ;
Marinos, G ;
Goncales, FL ;
Haussinger, D ;
Diago, M ;
Carosi, G ;
Dhumeaux, D ;
Craxi, A ;
Lin, A ;
Hoffman, J ;
Yu, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) :975-982
[2]   Peginterferon alfa-2a (40 KD) (pegasys) in combination with ribavirin (RBV): Efficacy and safety results from a phase III, randomized, double-blind, multicentre study examining effect of duration of treatment and RBV dose [J].
Hadziyannis, SJ ;
Cheinquer, H ;
Morgan, T ;
Diago, M ;
Jensen, DM ;
Sette, H ;
Ramadori, G ;
Bodenheimer, HC ;
Marcellin, P ;
Lee, SD ;
Roberts, PJ ;
Ackrill, AM .
JOURNAL OF HEPATOLOGY, 2002, 36 :3-3
[3]   Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus [J].
Poynard, T ;
Marcellin, P ;
Lee, SS ;
Niederau, C ;
Minuk, GS ;
Ideo, G ;
Bain, V ;
Heathcote, J ;
Zeuzem, S ;
Trepo, C ;
Albrecht, J .
LANCET, 1998, 352 (9138) :1426-1432
[4]   Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-α [J].
Sherman, M ;
Marinos, G ;
Sedarati, F .
ANNALS OF INTERNAL MEDICINE, 2001, 135 (10) :927-928
[5]   Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-α [J].
Zylberberg, H ;
Chaix, ML ;
Bréchot, C .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (10) :845-846